Acro Biomedical (ACBM) Net Income (2016 - 2026)

Acro Biomedical has reported Net Income for 11 years, with the latest figure at -$17554.0 in Q2 2026.

• On a quarterly basis, Net Income fell 12.8% year-over-year to -$17554.0 in Q2 2026; TTM through Jun 2026 was -$87158.0, a 130.07% decrease from a year earlier, with the FY2025 full-year figure at -$79905.0, down 139.13% from the prior year.
• Net Income was -$17554.0 for Q2 2026 at Acro Biomedical, down from $63767.0 in the prior quarter.
• The five-year high for Net Income was $1.8 million in Q4 2023, with the low at -$4.0 million in Q3 2022.
• Average Net Income over 5 years is -$1.4 million, with a median of -$17554.0 recorded in 2026.
• The sharpest annual moves came in 2022 and 2025: Net Income slumped 6503.69% in 2022, then soared 3660.41% in 2025.
• Over 5 years, Net Income stood at -$3.9 million in 2022, then soared by 146.54% to $1.8 million in 2023, then tumbled by 100.1% to -$1791.0 in 2024, then jumped by 3660.41% to $63767.0 in 2025, then tumbled by 127.53% to -$17554.0 in 2026.
• The last three Net Income figures came in at -$17554.0 (Q2 2026), $63767.0 (Q4 2025), and -$117809.0 (Q3 2025), per Business Quant data.